Clinical Trial Update: Safety Study of Rabies Vaccine INDIRAB® Five Doses (0.5ml) Post Exposure Administered Intramuscularly [NA]

View source ↗

Summary

This clinical trial update reports a completed safety study of the INDIRAB rabies vaccine given post-exposure as five intramuscular doses of 0.5 ml. The sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• INDIRAB® (Rabies vaccine)

Snippet

Sponsor: Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products | Conditions: Rabies | NA | Status: COMPLETED